TSE:MBX Microbix Biosystems (MBX) Stock Price, News & Analysis C$0.30 0.00 (0.00%) As of 07/3/2026 11:08 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Microbix Biosystems Stock (TSE:MBX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Microbix Biosystems alerts:Sign Up Key Stats Today's RangeC$0.30▼C$0.3050-Day RangeC$0.23▼C$0.3152-Week RangeC$0.21▼C$0.34Volume7,760 shsAverage Volume55,771 shsMarket CapitalizationC$41.25 millionP/E RatioN/ADividend Yield2.30%Price TargetN/AConsensus RatingN/A Company Overview Microbix Biosystems Inc. creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs or QUANTDx are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors. Read More Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBX Stock News HeadlinesAnalyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified DemandMay 17, 2026 | tipranks.comMicrobix Biosystems Inc.: Microbix Schedules Release of Results for Q2 Fiscal 2026May 8, 2026 | finanznachrichten.deStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.July 5 at 1:00 AM | Porter & Company (Ad)Microbix Schedules Release of Results for Q2 Fiscal 2026May 8, 2026 | finance.yahoo.comMicrobix Biosystems Inc.: Microbix Product Results Being Presented at 2026 PASCVApril 27, 2026 | finanznachrichten.deMicrobix Product Results Being Presented at 2026 PASCVApril 27, 2026 | finance.yahoo.comMicrobix Presenting at the 2026 Bloom Burton ConferenceApril 16, 2026 | theglobeandmail.comMicrobix to Court Global Healthcare Investors at 2026 Bloom Burton ConferenceApril 16, 2026 | tipranks.comSee More Headlines MBX Stock Analysis - Frequently Asked Questions How have MBX shares performed this year? Microbix Biosystems' stock was trading at C$0.23 on January 1st, 2026. Since then, MBX shares have increased by 30.4% and is now trading at C$0.30. How were Microbix Biosystems' earnings last quarter? Microbix Biosystems Inc. (TSE:MBX) announced its quarterly earnings results on Thursday, May, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $3.38 million during the quarter. Microbix Biosystems had a negative net margin of 38.62% and a negative trailing twelve-month return on equity of 21.02%. Read the conference call transcript. How do I buy shares of Microbix Biosystems? Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Microbix Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), Organigram (OGI), VEON (VEON) and Company Calendar Last Earnings5/14/2026Today7/05/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:MBX CIKN/A Webmicrobix.com Phone+1-905-3618910FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.04) Trailing P/E RatioN/A Forward P/E Ratio15.00 P/E GrowthN/ANet IncomeC$3.39 million Net Margins-38.62% Pretax MarginN/A Return on Equity-21.02% Return on Assets3.82% Debt Debt-to-Equity Ratio27.03 Current Ratio5.35 Quick Ratio5.57 Sales & Book Value Annual SalesC$14.81 million Price / Sales2.78 Cash FlowC$0.07 per share Price / Cash Flow4.13 Book ValueC$0.18 per share Price / Book1.65Miscellaneous Outstanding Shares137,501,000Free FloatN/AMarket CapC$41.25 million OptionableNot Optionable Beta0.68 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (TSE:MBX) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
